Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain × Triamcinolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pain 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hodgkin Disease 1 Dermatitis, Contact 1 Dendritic Cell Sarcoma, Interdigitating 1 Chalazion 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1 Adenomyosis 1

Interventions

Surveys and Questionnaires 14 Acupuncture Therapy 14 Fentanyl 12 Acetaminophen 12 Lidocaine 11 Analgesia 11 Morphine 10 Ketamine 10 Therapeutics 9 Ropivacaine 9 Methadone 9 Bupivacaine 9 Psychiatric Rehabilitation 8 Oxycodone 7 Hydromorphone 7 Water 5 Radiotherapy 5 Music Therapy 5 Methods 5 Early Intervention, Educational 5 Control Groups 5 Zoledronic Acid 4 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Saline Solution 4 Electroacupuncture 4 Colonoscopy 4 Calcium Dobesilate 4 Analgesics, Opioid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡